World Generic Markets Issue - More Work Necessary For WHO To Break Biosimilar Naming Stalemate - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "World Generic Markets Issue 280 (V15 I13)" report to their offering.

The issue of naming biosimilars and biologics in ways that enhances safety monitoring continues to be a contentious one; the generic industry is becoming increasingly implacable in its opposition to the WHO's Biological Qualifiers solution. Coupled with the US FTC's anticompetitive concerns over the FDA's approach to naming, a growing stalemate is emerging. The WHO will need to spend more time on the issue if an acceptable pathway is to be created."

Key Topics Covered:

  1. More Work Necessary For WHO To Break Biosimilar Naming Stalemate
  2. Teva Canada Launches Abacavir+Lamivudine
  3. Teva Completes Rimsa Acquisition
  4. Celgene Receives Paclitaxel ANDA Notice
  5. Alvogen To Acquire County Line Pharmaceuticals
  6. Aurobindo Gains US Acetylcysteine Approval
  7. Legislation Will Tackle Price-Gouging Symptoms But Not Cause
  8. Teva Launches Budesonide Inhalation Suspension
  9. New US Approvals For Hikma
  10. Fougera To Consolidate Two New York Facilities
  11. ANI To Acquire Propranolol Assets From Cranford
  12. Confluence Of ANDA Backlog And Pricing Issues Will Maintain Pressure On FDA
  13. Teva Acquisition Of Allergan Generics Edges Closer With Key European Approval
  14. EGA Changes Name To Medicines For Europe
  15. Gedeon Richter Expands Debrecen Biotech Plant
  16. Altan Enters Caspofungin Licensing Agreement
  17. Dr Reddy's Enters Biosimilars Collaboration With TR-Pharm
  18. Lupin On Course To Cement Place In US Market
  19. Prevnar 13 Patent Attack Will Pressure Indian Patent Office
  20. Debiopharm Sees Victory In Japanese Oxaliplatin Lawsuit
  21. Aspen Will Look To Offset Foreign Currency Weaknesses

For more information visit http://www.researchandmarkets.com/research/8pvz6d/world_generic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs